InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.13
(
0.09%
)
US TECH 100
18,188.00
(
-0.05%
)
Dow Jones
39,806.77
(
0.00%
)
Brent Oil
82.30
(
-1.47%
)
Bitcoin
71,382.25
(
-0.09%
)
Post# of 146
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

MiamiGent

Send PM Follow Ignore
Followers 272
Posts 53189
Boards Moderated 3
Alias Born 08/16/2008

MiamiGent

Member Level

Re: MiamiGent post# 51

Monday, 07/13/2020 11:42:44 PM

Monday, July 13, 2020 11:42:44 PM

Post# of 146
EQ Itolizumab "is a breakthrough drug for treating autoimmune disease"

"the outcome of this open label test was so compelling"

"The drug works to treat this great disease!"

Kiran Mazumdar Shaw
Chairperson Biocon
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent EQ News
More EQ News
InvestorsHub NewsWire

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!